Crunch Time For Aerie At EMA
An EU Marketing Recommendation Could Be In Store For New Glaucoma Treatment
Executive Summary
Aerie is already exploring its pricing strategy for Roclanda as the European Medicines Agency this week decides whether the intraocular pressure treatment should be approved in Europe.
You may also be interested in...
Phesgo & Roclanda Among New Winners At EMA
The European Medicines Agency this week recommended that five new products be granted EU marketing approval.
Advanced Therapy Developers Urged To Monitor Major EU Proposal On Using Blood, Tissues & Cells
Companies have the opportunity to tell the European Commission what they think about its proposed regulation that would overhaul the rules governing the use of substances of human origin.
Accelerated Assessment Dry Spell Over As EMA Says Yes To Pharming’s Leniolisib
Leniolisib has become the first product to be granted accelerated assessment status by the European Medicines Agency this year.